VanEck Genomics and Healthcare Innovators UCITS ETF A

VanEck UCITS ETF tracking global genomics and e-healthcare companies with ESG screening, offering investors exposure to healthcare innovation worldwide.

ISIN IE000B9PQW54TER 0.35% TERInception 02 Sept 2022Policy AccumulatingProvider VanEck

See below how EuroFolio members build portfolios around CURE, and which ETFs they most commonly pair with it.

Fund Details

Available Exchanges

XETRA(EUR)US(USD)

Index TrackedMVIS Global Future Healthcare ESG

ReplicationPhysical

StrategyLong-only

Currency RiskCurrency unhedged

Fund DomicileIreland

Fund CurrencyUSD